The identification of the target proteases that interact with the 25-kDa form of HAI-2 may reveal those proteases as potential targets for anti-cancer therapeutics, and the expression and aberrant subcellular localization of the two HAI-2 forms might have potential as cancer biomarkers. The gene discussed is SPINT2; the disease is cancer.